Constructive Bio raises $58M for synbio work and Sir Gregory Winter joins board
UK-based synthetic biology startup, Constructive Bio, has secured $58 million in funding from private investors to further its work in engineering cell systems for... Read more.
Alchemab Appoints Jane Osbourn as Chief Executive Officer
A veteran of the biopharmaceutical industry with a distinguished career spanning over three decades, Osbourn is recognised for her pioneering work in antibody research... Read more.
Vicebio Announces $100M Series B Financing for Clinical Study of RSV/hMPV Bivalent Vaccine
London-based biopharmaceutical company Vicebio Ltd has raised $100 million in a Series B financing round to support the development of its respiratory virus vaccine... Read more.
Mission Street and BGO get go-ahead for 23-acre central Cambridge science district
Cambridge City Council has given the green light to a major new science district, set to become one of the largest urban research hubs in the UK. The development,... Read more.